- Home
- INSW vs BCRX Comparison
INSW vs BCRX Comparison
Compare INSW & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSW
- BCRX
- Stock Information
- Founded
- INSW 1999
- BCRX 1986
- Country
- INSW United States
- BCRX United States
- Employees
- INSW N/A
- BCRX N/A
- Industry
- INSW Semiconductors
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INSW Technology
- BCRX Health Care
- Exchange
- INSW Nasdaq
- BCRX Nasdaq
- Market Cap
- INSW 1.7B
- BCRX 1.7B
- IPO Year
- INSW N/A
- BCRX 1994
- Fundamental
- Price
- INSW $37.73
- BCRX $9.97
- Analyst Decision
- INSW Strong Buy
- BCRX Buy
- Analyst Count
- INSW 3
- BCRX 8
- Target Price
- INSW $56.67
- BCRX $16.75
- AVG Volume (30 Days)
- INSW 744.2K
- BCRX 6.1M
- Earning Date
- INSW 05-08-2025
- BCRX 05-05-2025
- Dividend Yield
- INSW 10.88%
- BCRX N/A
- EPS Growth
- INSW N/A
- BCRX N/A
- EPS
- INSW 6.47
- BCRX N/A
- Revenue
- INSW $860,606,000.00
- BCRX $503,485,000.00
- Revenue This Year
- INSW N/A
- BCRX $27.64
- Revenue Next Year
- INSW $1.20
- BCRX $13.42
- P/E Ratio
- INSW $5.82
- BCRX N/A
- Revenue Growth
- INSW N/A
- BCRX 41.67
- 52 Week Low
- INSW $27.20
- BCRX $5.06
- 52 Week High
- INSW $65.94
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- INSW 65.98
- BCRX 65.89
- Support Level
- INSW $35.75
- BCRX $9.83
- Resistance Level
- INSW $37.23
- BCRX $11.11
- Average True Range (ATR)
- INSW 1.17
- BCRX 0.51
- MACD
- INSW 0.50
- BCRX 0.20
- Stochastic Oscillator
- INSW 96.67
- BCRX 68.33
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.